Drugs Market Research Reports & Industry Analysis

... analog market in 2011. In April 2012, the insulin phase Ⅲ project of the company held the groundbreaking ceremony. Once the project is put ... . The report highlights the followings: Global insulin industry: development, supply & demand, product R&D, competition pattern, development trend, etc. China insulin ...

... , a leading global management consulting and market research firm, has analyzed the global diabetes drugs industry and presents its findings in “Global Diabetes Drugs Industry 2013-2018: Trend, Profit, and Forecast Analysis.” The diabetes drugs industry is highly consolidated with all classes of drugs ...

... from Venture Planning Group contains 311 pages and 61 tables. 'Drugs of Abuse Testing Market: US, Europe, Japan' is a unique study designed to help current ... start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace ...

... , with the increasing recognition rate of doctors for depression and people's changes in treatment concepts, it is expected that the future potential of China's antidepressant market is fairly great. It is predicted that in coming years, the annual growth rate of market size of China's antidepressants in ...

... of fungi increasingly enhances, so it indicates a sharply rising trend for the clinical application of antifungal drugs. It is expected that in coming years, the annual growth rate of market size of China's antifungal drugs will be over 20%. As for manufacturers, there are many opportunities. ...

... aged above 20 has reached over 9.7%, and the morbidity rate of pre-diabetes (impaired fasting glucose and impaired glucose tolerance) has reached ... the market positions of insulin preparations and Acarbose. The market size of China's diabetes drugs is expected to maintain an annual growth rate of over 18% from ...

... , the morbidity and mortality rates of cardiac-cerebral thrombotic diseases in China are higher than that in some developed countries. In addition, patients ... aggregation drugs and thrombolytic drugs. The overall market size of China's antithrombotic drugs is small, but it rapidly grows in recent years. The ...

... a competitive analysis of the leading global cardiovascular drugs companies and presents its findings in “Top Five Global Cardiovascular Drug Companies: Performance, Strategies, and Competitive Analysis ... to provide industry leaders with a competitive benchmarking of the world’s top five cardiovascular drugs companies. The study provides up-to-date information on the market share ...

... , the overall morbidity rate of dyslipidemia groups aged 18 and above is over 20% in China, and total patients are over 200 million nationwide. Blood ... , thus occupying a most advantageous position clinically. The overall performance of China's hypolipidemic drugs in the drug market is better than that of the ...

... pts – GT1, Null, and Naïve seems to have become the norm. At AASLD 2012: (i) GILD presented interim data from the ongoing PhII ... , please read our report released on 20th Nov. 2012, titled, 'Hepatitis C: UPDATE Post AASLD ’12 - Progress in IFN-Free Drugs & Vaccines - Gilead and Abbott vying ...

... five years, from 2012-2017, will see the launch of many new drugs. Scope of the Report The Alzheimer’s drug market (2011-2017) ... III clinical trials. Chapter 8 provides profiles of the key companies in this market. Each company profile includes information such as financial performance, geographical ...

... Inhibitors and IL-6 Receptor (IL-6R) Antagonists for treatment of rheumatoid arthritis and multiple myeloma provides a competitor evaluation in the field of R&D projects with Interleukin-6 (IL-6) Inhibitors and IL-6 Receptor (IL-6R) Antagonists as of October 2012. Purchase of the downloadable pdf report ...

... is already available on the market, e.g., DNA extractors, DNA synthesizers, thermal cyclers, robotic work-stations, and automated DNA probe analysis systems. The report reviews current instrumentation technologies, and compares features of leading molecular diagnostics analyzers marketed by Abbott, Beckman ...

... clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing ... . This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios ...

... This report provides you concise information about the vitamin B2 industry in China, discovering not only the latest dynamics of production situation and producers ... , but also price, import and export, and the application fields of the vitamin B2 products. Besides, ...

... , a leading global management consulting and market research firm, has analyzed the global generic drugs industry and presents its findings in Global Generic Drugs Industry 2012-2017: Trend, Profit, and Forecast Analysis. The industry comprises firms primarily engaged in the development, manufacture, and marketing of generic drugs. The generic ...

During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will ...

During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling ...

... over 2012-2017 and reach an estimated $174.8 billion by 2017. Lucintel, a leading global management consulting and market research firm, has analyzed the global cardiovascular drugs industry and offers its findings in its research report, “Global Cardiovascular Drugs Industry 2012-2017 ...

Chemosynthetic polypeptide drugs are drugs combining the certain amino acids in chemical methods, which are characterized by favorable curable effects, few side-effects, high specificities and other a...

Drug resistance is a growing concern worldwide and Cempra (CEMP) is one of our lead recommendations ... offer an attractive investment opportunity in this therapy class. CEMP’s lead drug, 1. Solithromycin (CEM-101, PhIII, CABP; PhII cUTI) ... released on 2nd July, 2012 on CEMP titled “GAIN from Drugs for Bad Bugs”

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides ... , Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, ...

... crucial aspects of growth strategy for a generic company or an Active Pharmaceutical Ingredient manufacturing ... recently approved or are in late stage development / Filed but with significantly success probability ... / therapeutic value compared to marketed drugs Anticipated competition in the therapy and ...

... days after order is placed. Over-the-counter drug market in India ranks eleventh in the global OTC market and is expected to reach the ninth position ... tendency for self treatment, the Indian market is characterized by a huge demand for OTC drugs. It is a highly fragmented market with a large number of foreign ...

In volume of transaction, Vitamin E is one of the world's top three vitamins with annual global market volume of nearly USD1 billion, thanks to the wide range of applications in feed, medicine and foo...

The real potential for orphan drug pharma marketing With drug pipelines moving from essential products to niche therapies, large pharma companies are increasingly attracted to the prospective high de...

In the global biopharmaceutical industry, protein-based therapies are effectively being used to treat metabolic disorders, and autoimmune diseases. According to our new research report, the global mar...

... details, please read our report released on 9th May, 2012 on Halozyme titled “HyQvia’s Delay – Percolation to Other Drugs in the Pipeline?”

... report analyzes the worldwide markets for Kidney Cancer Drugs in US$ Million. This report on 'Kidney Cancer Drugs' provides market analytics specifically for ... Ltd., GlaxoSmithKline Plc, Merck-Serono, Novartis AG, Pfizer, Inc., and WILEX AG. Market data and analytics are derived from primary and secondary ...

... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...

... variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "Therapeutic Dry Monitoring: US, Europe, Japan" is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants ...

... the Global Drug Retail market and presents its findings in “Global Retail Drug Industry 2012-2017: Trend, Profit, and Forecast Analysis.” The drug industry consists of pharmacies and drug ... (Q1 2012 – Q4 2012) for global drugs retail industry analysis Gross and net profit trends in the global drugs retail industry analysis Cost structure trend in the global as well as regional global drugs retail industry ...

... Global Drug Retail market and presents its findings in -Global Retail Drug Industry Analysis 2012-2017: Industry Trend, Profit, and Forecast Analysis. The Drug industry consists of pharmacies and drug stores engaged in retailing prescription or nonprescription drugs and ...

This report analyzes the worldwide markets for RNA Interference (RNAi) in US$ Million by the following Application Areas: Drug Discovery and Target ... , Inc., Exiqon A/S, Genesis Research & Development Corporation Limited, Halo-Bio RNAi Therapeutics, Inc., Marina Biotech, Inc., OPKO Health, Inc., Polyplus- ...

... falling, leading to layoffs and cuts in research budgets. While the US drug industry is hardly in a full-blown crisis, however, layoffs are occurring ... taken once a week instead of daily. Aruvian's R'search analyzes the United States Drug Industry in the Michael Porter’s Five Forces Analysis. It uses concepts ...

Hepatitis C virus drug market is experiencing a dramatic near-term growth, by crossing US$ 6 Billion in 2011 and is expected to be more than double of its current figure by 2015. This robust growth wi...

Between now and 2019, a vast range of blockbuster drugs will go off patent, opening the floodgates in the EU to the biosimilars market. Already established there since 2006, biosimilars are set to be...

Canada is one of the world’s largest pharmaceutical markets, even though it has a low share of only 3% in global pharma industry. In 2010, generics accounted for more than 57% prescriptions and around...

... to moderate RA pts population where biologics have not made a dent. At ACR 2011 (Nov. 5-9, 2011, Chicago), key data on safety and efficacy ... read our meeting preview report released on 1st Nov, 2011 on “Rheumatoid Arthritis: Battlefield at ACR ’11 - Next Wave: Innovative Oral Drugs for RA”.

... Study of Liver Diseases (AASLD) 2011 (Nov. 4 - Nov. 8, San Francisco) will unveil - Data and new approaches to treat Hepatitis C Viral Infection (HCV ... our Therapeutic Class Overview report released on 31st October, 2011 on Hepatitis C: AASLD 2011 titled “Next Wave: IFN-Free Drugs with Safety ...

Osteoporosis Market Overview Osteoporosis is often called the ""silent disease"" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-archite...

... information and analysis of the leading players in the Global Cardiovascular Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... , demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...

... product segments: ethical, OTC, generics. Sales forecast for major drug categories. Sales forecasts by geographical region: North America, Europe, Japan, ... , capabilities, goals and strategies of the leading players in the global CNS drug market. To help current suppliers realistically assess their financial ...

... information and analysis of the leading players in the Global Oncology Drug Market. The report provides a worldwide strategic overview of the pharmaceutical ... economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key ...

... Product description This report “Antibody-Drug Conjugates 2011 – real breakthrough still to come: A Technology, Stakeholder and R&D Pipeline Analysis” published in September ... still narrow the therapeutic window for the currently used drugs and linkers. Nevertheless, about half of the currently clinical stage ...

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,800.00 Hard Copy: US$ 1,200.00 CD-ROM: US$ 1,200.00 The world has witnessed a sharp increase in the demand for cost-effec...

Schizophrenia is a mental disorder characterized by disintegration of thought processes and of emotional responsiveness. It most commonly manifests as auditory hallucinations, paranoid or bizarre delu...

Single User PDF Format: US$ 1,000.00 Multi-User License: US$ 1,500.00 Hard Copy: US$ 1,100.00 CD-ROM: US$ 1,100.00 The obesity epidemic has been disseminating among developed countries as well as low...

Alzheimer’s is a complex disease and there is no single “magic bullet” available in the market to prevent or cure it. Though many marketed drugs have been approved for Alzheimer’s disease, but it stil...